Metabolomic and Genetic Analysis of Biomarkers for Peroxisome Proliferator-Activated Receptor α Expression and Activation
Open Access
- 1 September 2007
- journal article
- other
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 21 (9) , 2136-2151
- https://doi.org/10.1210/me.2007-0150
Abstract
Peroxisome proliferator-activated receptor α (PPARα) is a nuclear receptor with manifold effects on intermediary metabolism. To define a set of urinary biomarkers that could be used to determine the efficacy of PPARα agonists, a metabolomic investigation was undertaken in wild-type and Pparα-null mice fed for 2 wk either a regular diet or a diet containing the PPARα ligand Wy-14,643 ([4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid), and their urine was analyzed by ultra-performance liquid chromatography coupled with time-of-flight mass spectrometry. Principal components analysis of 6393 accurate mass positive ions revealed clustering as a single phenotype of the treated and untreated Pparα (−/−) mice plus two additional discrete phenotypes for the treated and untreated Pparα (+/+) mice. Biomarkers of PPARα activation were identified from their accurate masses and confirmed by tandem mass spectrometry of authentic compounds. Biomarkers were quantitated from raw chromatographic data using appropriate calibration curves. PPARα urinary biomarkers highly statistically significantly elevated by Wy-14,643 treatment included 11β-hydroxy-3,20-dioxopregn-4-en-21-oic acid (>3700-fold), 11β,20-dihydroxy-3-oxopregn-4-en-21-oic acid (50-fold), nicotinamide (>2-fold), nicotinamide 1-oxide (5-fold), 1-methylnicotinamide (1.5-fold), hippuric acid (2-fold), and 2,8-dihydroxyquinoline-β-d-glucuronide (3-fold). PPARα urinary biomarkers highly statistically significantly attenuated by Wy-14,643 treatment included xanthurenic acid (1.3-fold), hexanoylglycine (20-fold), phenylpropionylglycine (4-fold), and cinnamoylglycine (9-fold). These biomarkers arise from PPARα effects on tryptophan, corticosterone, and fatty acid metabolism and on glucuronidation. This study underscores the power of mass spectrometry-based metabolomics combined with genetically modified mice in the definition of monogenic metabolic phenotypes.Keywords
This publication has 35 references indexed in Scilit:
- Regulation of Mouse Hepatic α-Amino-β-Carboxymuconate-ϵ-Semialdehyde Decarboxylase, a Key Enzyme in the Tryptophan-Nicotinamide Adenine Dinucleotide Pathway, by Hepatocyte Nuclear Factor 4α and Peroxisome Proliferator-Activated Receptor αMolecular Pharmacology, 2006
- Significance of the Minor Cytochrome P450 3A IsoformsClinical Pharmacokinetics, 2006
- Silver Nitrate: Versatile Reagent in Organic SynthesisSynlett, 2005
- Development of a multivariate statistical model to predict peroxisome proliferation in the rat, based on urinary1H-NMR spectral patternsBiomarkers, 2004
- The UDP-glucuronosyltransferase 1A9 Enzyme Is a Peroxisome Proliferator-activated Receptor α and γ Target GenePublished by Elsevier ,2003
- Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: identification ofN-methylnicotinamide andN-methyl-4-pyridone-3-carboxamide by1H nuclear magnetic resonance and high performance liquid chromatographyBiomarkers, 2003
- Quantitative Structure Activity Relationships for the Glucuronidation of Simple Phenols by Expressed Human UGT1A6 and UGT1A9Drug Metabolism and Disposition, 2002
- Peroxisome Proliferator-activated Receptor-α Regulates Lipid Homeostasis, but Is Not Associated with ObesityJournal of Biological Chemistry, 2001
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999
- Synthesis of corticosteroid derivatives containing the 20.beta.-Ol-21-al side chainThe Journal of Organic Chemistry, 1976